A new malaria vaccine which has shown efficient results and proved to be safe has been tested on humans and mice. The vaccine uses a weakend version of P. falciparum.
Researchers undergo first phase trials on mice and humans using a weakened variant of malarial parasite, which doesn't cause malaria infection rather, it formed antibodies.
